At Health from Space 2026 in Cannes, organized under the aegis of CNES and the European Space Agency, DeltaWave opened Panel 10, "The Pharmaceutical Revolution", with a keynote on AI, space biology, and drug discovery.

The talk introduced how EVE and PCP work together: EVE automates molecular design with agentic AI, while PCP is designed for distributed training across heterogeneous, high-latency, and unstable environments, including air-gapped settings and future space-based data workflows.

The panel brought together leaders from Roche Diagnostics France, SpacePharma-EU, InnoAdvance, and Space LiinTech to discuss how microgravity research, AI, and pharmaceutical R&D can reshape medicine.